Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Overall Study	STARTED	Intravenous Levetiracetam	64
Overall Study	STARTED	Intravenous Phenobarbital	42
Overall Study	Recieved Second Infusion of Same Drug	Intravenous Levetiracetam	50
Overall Study	Recieved Second Infusion of Same Drug	Intravenous Phenobarbital	20
Overall Study	Recieved Alternate Intervention	Intravenous Levetiracetam	45
Overall Study	Recieved Alternate Intervention	Intravenous Phenobarbital	10
Overall Study	Received 2nd Infusion of Alternate Drug	Intravenous Levetiracetam	27
Overall Study	Received 2nd Infusion of Alternate Drug	Intravenous Phenobarbital	6
Overall Study	Modified ITT	Intravenous Levetiracetam	53
Overall Study	Modified ITT	Intravenous Phenobarbital	30
Overall Study	COMPLETED	Intravenous Levetiracetam	60
Overall Study	COMPLETED	Intravenous Phenobarbital	41
Overall Study	NOT COMPLETED	Intravenous Levetiracetam	4
Overall Study	NOT COMPLETED	Intravenous Phenobarbital	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01720667/flow